Excellent survival after allogeneic HSCT in screened SCID patients and donor type dependent naïve T cell

Kajetan Trojovsky1, Friedhelm R Schuster1, Hans-Jürgen Laws1

  • 1Division of Pediatric Stem Cell Therapy, Department of Pediatric Oncology, Hematology and Clinical Immunology, Medical Faculty, Heinrich-Heine-University, Duesseldorf, Germany.

Abstract

No abstract available in PubMed .